MannKind Q2 FY26 net loss widens to $19.03 million; revenue rises 43% to $109.37 million
Reuters2026/08/05 20:02- MannKind posted Q2 revenue of USD 109.37 million, up 43% year over year.
- Operating results swung to an operating loss of USD 350,000 from operating income.
- Net results turned to a loss of USD 19.03 million, or USD 0.06 per share, from net income.
- Furoscix net sales were USD 22.19 million; Afrezza net sales fell 7% to USD 17.02 million.
- FDA cleared Afrezza for ages 6+; Furoscix ReadyFlow autoinjector won approval, expected to reach market in late August.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs evaluates Apple's foldable iPhone: Pricing is “affordable,” with shipments this year reaching up to 35 million units
A Goldman Sachs report indicates that iPhone Duo, with its "thinnest ever" design and "affordable" pricing, is expected to open up the mass market. The forecast for 2026 remains at 14 to 35 million units shipped. The new product's upgrades in hinges, cooling, and camera technologies will benefit the supply chain in Greater China, including Foxconn.
Edyoutec partners with Skiply to sell 10Monkeys subscriptions in UAE from Sept. 15
Nissan reorganizes Japan manufacturing footprint, shifts vehicle production among plants
Crypto prices
More
